To include your compound in the COVID-19 Resource Center, submit it here.

Generation Bio debuts with $25M A round

Gene therapy company Generation Bio Co. (Cambridge, Mass.) emerged from stealth mode on Jan. 4 with a $25 million series A round from Atlas

Read the full 244 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE